<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E1FFE52A-F49B-4B37-A550-35D31FAB3126"><gtr:id>E1FFE52A-F49B-4B37-A550-35D31FAB3126</gtr:id><gtr:name>Coll?ge de France</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/42D1A689-5159-45DF-BFC6-3C61D9ACDA6B"><gtr:id>42D1A689-5159-45DF-BFC6-3C61D9ACDA6B</gtr:id><gtr:name>Saclay Nuclear Research Centre</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:department>Biology and Biochemistry</gtr:department><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1FFE52A-F49B-4B37-A550-35D31FAB3126"><gtr:id>E1FFE52A-F49B-4B37-A550-35D31FAB3126</gtr:id><gtr:name>Coll?ge de France</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/42D1A689-5159-45DF-BFC6-3C61D9ACDA6B"><gtr:id>42D1A689-5159-45DF-BFC6-3C61D9ACDA6B</gtr:id><gtr:name>Saclay Nuclear Research Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/63BC77F4-4FEF-4378-B4D4-C6A6293B4B90"><gtr:id>63BC77F4-4FEF-4378-B4D4-C6A6293B4B90</gtr:id><gtr:firstName>Ravi</gtr:firstName><gtr:surname>Acharya</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601973"><gtr:id>81764C4D-F3C7-4F43-9066-CA028FD1E80D</gtr:id><gtr:title>Structural studies on human Angiotensin-I converting enzyme (ACE) and the design of novel structure-based inhibitors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601973</gtr:grantReference><gtr:abstractText>Angiotensin-I converting enzyme (ACE) inhibitors are widely used to treat cardiovascular diseases, including high blood pressure, heart failure, coronary artery disease and kidney failure. However, current-generation ACE inhibitors, which were developed in the 1970?s and 1980?s, are hampered by common side effects. This underscores the importance of the determination of the 3D structure of ACE and the design of 2nd generation ACE-inhibitor complex/s that are safer and more effective. Our success in the determination of the crystal structure of human testis ACE (Natesh et al., 2003) and recently the N-domain of somatic ACE (Corradi et al., 2006) using X-ray crystallography have provided the platform for true structure-based design of ACE inhibitors. This is a significant breakthrough in terms of the structural biology of the protease and, more importantly, the mechanism of ACE inhibition. This paves the way for a more rigourous approach exploiting the differences between the domains through a structure based drug design approach of novel domain-selective inhibitors. Our proposed experiments are directed at structural study of the full-length somatic ACE and crystal structures of complexes of ACE with domain selective inhibitors will be determined through a collaborative effort with Dr. Sturrock (UCT, South Africa) and Cresset Ltd (UK).</gtr:abstractText><gtr:technicalSummary>Angiotensin I-converting enzyme (ACE) plays a critical role in blood pressure regulation. The clinical success of the 1st generation ACE inhibitors in the treatment of hypertension, congestive heart failure, renal insufficiency and atherosclerosis is well established. However, current-generation ACE inhibitors are frequently not tolerated and do not discriminate between the two active sites of somatic ACE, located in the N- and C-terminal domains, respectively. The N-and C-domain active sites are significantly different. Hence, the development of novel domain selective inhibitors by structure-based drug design will produce inhibitors with the potential for greater efficacy, fewer side effects, and treatment of new indications (e.g., polycythemia). Toward this goal, we have been successful in determining the 3D structure of testis ACE [identical to the C-domain of somatic ACE (Natesh et al., 2003)] and recently the N-domain of somatic ACE (Corradi et al., 2006) in collaboration with Dr. E. D. Sturrock (UCT, South Africa). The long term objective of this proposal is to develop novel ACE inhibitors for the treatment of hypertension based on the 3D structures of testis and somatic protein. This research would also help in better understanding the relationship between the structure and function of both testis and somatic ACE.</gtr:technicalSummary><gtr:fund><gtr:end>2011-04-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>355117</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biology</gtr:department><gtr:description>Academic collaboration</gtr:description><gtr:id>5995E18D-9676-44FE-8552-B6BD07E16612</gtr:id><gtr:impact>Outcome - Peer-Reviewed Research publications 

Multi-disciplinary collaboration</gtr:impact><gtr:outcomeId>tedJE4nHW36-2</gtr:outcomeId><gtr:partnerContribution>Professor Edward Sturrock's group (Cape Town, Soth Africa) - Biochemistry

Profoessor Elwyn Isaac's group (Leeds, UK) - Enzymology

Professor Pierre Corvol's group (Paris, France) - Medical Biochemistry

Dr. Vincent Dive (CEA, France)- Medicinal Chemistry</gtr:partnerContribution><gtr:piContribution>Professor Ravi Acharya's group (Bath) - Structural Biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Coll?ge de France</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Centre for Interdisciplinary Research in Biology</gtr:department><gtr:description>Academic collaboration</gtr:description><gtr:id>85DB7C92-A385-4BAC-A6EC-659FD3A1A0DC</gtr:id><gtr:impact>Outcome - Peer-Reviewed Research publications 

Multi-disciplinary collaboration</gtr:impact><gtr:outcomeId>tedJE4nHW36-3</gtr:outcomeId><gtr:partnerContribution>Professor Edward Sturrock's group (Cape Town, Soth Africa) - Biochemistry

Profoessor Elwyn Isaac's group (Leeds, UK) - Enzymology

Professor Pierre Corvol's group (Paris, France) - Medical Biochemistry

Dr. Vincent Dive (CEA, France)- Medicinal Chemistry</gtr:partnerContribution><gtr:piContribution>Professor Ravi Acharya's group (Bath) - Structural Biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Saclay Nuclear Research Centre</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Service d?Ing?nierie Mol?culaire des Prot?ines (SIMOPRO)</gtr:department><gtr:description>Academic collaboration</gtr:description><gtr:id>D4CF2FE2-2F68-439B-B4AE-2DC5D030FEA3</gtr:id><gtr:impact>Outcome - Peer-Reviewed Research publications 

Multi-disciplinary collaboration</gtr:impact><gtr:outcomeId>tedJE4nHW36-4</gtr:outcomeId><gtr:partnerContribution>Professor Edward Sturrock's group (Cape Town, Soth Africa) - Biochemistry

Profoessor Elwyn Isaac's group (Leeds, UK) - Enzymology

Professor Pierre Corvol's group (Paris, France) - Medical Biochemistry

Dr. Vincent Dive (CEA, France)- Medicinal Chemistry</gtr:partnerContribution><gtr:piContribution>Professor Ravi Acharya's group (Bath) - Structural Biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Institute of Infectious Disease and Molecular Medicine (IIDMM)</gtr:department><gtr:description>Academic collaboration</gtr:description><gtr:id>A2D1D12A-F648-45B1-BF5A-C54FD130F9A4</gtr:id><gtr:impact>Outcome - Peer-Reviewed Research publications 

Multi-disciplinary collaboration</gtr:impact><gtr:outcomeId>tedJE4nHW36-1</gtr:outcomeId><gtr:partnerContribution>Professor Edward Sturrock's group (Cape Town, Soth Africa) - Biochemistry

Profoessor Elwyn Isaac's group (Leeds, UK) - Enzymology

Professor Pierre Corvol's group (Paris, France) - Medical Biochemistry

Dr. Vincent Dive (CEA, France)- Medicinal Chemistry</gtr:partnerContribution><gtr:piContribution>Professor Ravi Acharya's group (Bath) - Structural Biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>447324</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant, G1001685</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FEAD399F-8F97-4AAA-B91E-EB35593B2E65</gtr:id><gtr:outcomeId>d6geWw1dY9b0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>X-ray diffraction data and Atomic coordinates of reported structures</gtr:description><gtr:id>EC01392E-9FCB-4388-9F20-F0B291FC4C9D</gtr:id><gtr:impact>The structural data are made available in the public domain. This will be useful for structure-based-drug-design research on Angiotensin-1 converting enzyme aimed at cardivascular diseases.</gtr:impact><gtr:outcomeId>E8NLAdAHHg5</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Deposition of Structural data with Protein Data Bank</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CA3EE368-4D50-45FB-81D4-53F6B09E2A7D</gtr:id><gtr:title>Spectroscopic and structural analysis of somatic and N-domain angiotensin I-converting enzyme isoforms from mesangial cells from Wistar and spontaneously hypertensive rats.</gtr:title><gtr:parentPublicationTitle>International journal of biological macromolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84beaaee3f7e341da1ecfbe5d080afda"><gtr:id>84beaaee3f7e341da1ecfbe5d080afda</gtr:id><gtr:otherNames>de Andrade MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0141-8130</gtr:issn><gtr:outcomeId>gtrquHp3KER</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>210D6EDE-AE23-4FE8-B5B1-7DAEFBD40CD4</gtr:id><gtr:title>Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1032891d06591a0949d99315696e2161"><gtr:id>1032891d06591a0949d99315696e2161</gtr:id><gtr:otherNames>Akif M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>kEFr3dpAToA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66C939B4-2CE6-4724-95E5-FE7172D9DA39</gtr:id><gtr:title>The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52dbc9bf99080dfb998e8693c0c395e1"><gtr:id>52dbc9bf99080dfb998e8693c0c395e1</gtr:id><gtr:otherNames>Anthony CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>iwvwY9tgZyC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C15D381C-4947-4362-995A-9F20CF9593BA</gtr:id><gtr:title>Crystal structure of a phosphonotripeptide K-26 in complex with angiotensin converting enzyme homologue (AnCE) from Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1032891d06591a0949d99315696e2161"><gtr:id>1032891d06591a0949d99315696e2161</gtr:id><gtr:otherNames>Akif M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>bmbv6STRmYq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61429233-0AD9-49A6-AC52-EFB450F9AFD8</gtr:id><gtr:title>High-resolution crystal structures of Drosophila melanogaster angiotensin-converting enzyme in complex with novel inhibitors and antihypertensive drugs.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1032891d06591a0949d99315696e2161"><gtr:id>1032891d06591a0949d99315696e2161</gtr:id><gtr:otherNames>Akif M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>BsNp6W6miWw</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601973</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>